Lymphoma

Explore the newest discoveries and latest clinical insights on lymphoma. Cancer Nursing Today provides the most current perspectives and data on predictive models for the prognosis of patients with diffuse large B-cell lymphoma, toxicities in triplet therapies, CAR T-cell therapies, and more. Explore the latest clinical trial data, conference coverage, and breaking news on lymphoma.

Role of SIRT1, EZH2, and CXCR4 Pathways in Treating Diffuse Large B-Cell Lymphoma
Robert E. Brown, MD, and collaborating researchers from the University of Texas Health Science Center at Houston McGovern Medical School in Houston, used morphoproteomics, a holistic approach to characterizing diseased cells, to reveal commonalities in the biology of patients with diffuse large B-cell lymphoma (DLBCL). According to the researchers’ report, published in Annals of Clinical and Laboratory Science, their analysis suggested that the SIRT1 (silent mating type information regulation 2 homolog 1), EZH2 (enhancer of Zeste homolog 2), and CXCR4 (C-X-C chemokine receptor 4) pathways could be effective avenues to target the biology of DLBCL. ...
Advertisement

Latest News

Advertisement

Knowledge Hub

Breast Cancer
Breast Cancer

Conference Highlights

June 16, 2022


Advertisement
Advertisement
Popular Stories